|
LQDA | Liquidia Corp |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 0.04 |
| Leverage | 81.27% |
| Market Cap | $ 5.6B |
| PE | 254.36 |
| Dividend Yield | 0.00% |
| Profit | $ 22.1m |
| Margin | 8.27% |
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and markets various products for the unmet needs of patients in the United States. The company is headquartered in Morrisville, North Carolina.